These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2004-002979-16 A Six-Week/Six-Week, Prospective, Randomised, Masked, Cross over, Primary Therapy Study comparing IOP Lowering Effects of Lumigan® and Xalatan® in Subjects with Primary Open Angle Glaucoma, Ocular Hy... 2006-08-08 due-trials
Ongoing 2005-000115-10 A randomised, double blind, placebo-controlled, cross-over study of the effects of dehydroepiandrosterone replacement on vascular function in patients with primary and secondary adrenal insufficiency. not-yet-due
Ongoing 2005-000749-13 A Randomised Double-Blind Trial of Medical Treatment In Marfan Syndrome. not-yet-due
Ongoing 2005-000817-37 A Study On The Efficacy Of Delta-9-Tetrahydrocannabinol (Dronabinol) In Renal Itch not-yet-due
Ongoing 2005-001291-12 Histamine Release and Implications of H1- and H2- Blockade in Adult Cardiac Surgery - A Randomised Controlled Study not-yet-due
Ongoing 2005-001588-78 AML16 Pilot Trial: A Phase1/2 Trial to assess the feasibility of combining Clofarabine with daunorubicin and Daunorubicin + Clofarabine with Mylotarg in older patients with Acute Myeloid Leukaemia and... not-yet-due
Ongoing 2005-002847-14 AML16; A National Cancer Research Institute Trial in Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndromes not-yet-due
Ongoing 2005-003681-42 The effects of Acacia (sen) SUPERGUM (Gum Arabic) on renal physiology and arterial function in type II diabetic patients not-yet-due
Ongoing 2005-004754-27 Comparison of insulin detemir and insulin glargine in patients with Type 2 diabetes not-yet-due
Ongoing, reported early 2005-005470-69 A randomised, double-blind, placebo-controlled crossover trial of the effects of metformin therapy on vascular and metabolic risk in young women with polycystic ovary syndrome. not-yet-due
Reported results 2006-004327-11 A randomised phase II multi-centre trial of topical treatment in women with vulval intraepithelial neoplasia 2014-01-24 due-trials
Ongoing 2007-000056-14 Determination of method-specific normal cortisol and adrenal hormone responses to the short Synacthen test not-yet-due
Ongoing 2007-003798-16 AML 17: A Programme of Treatment Development in Younger Patients with Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome not-yet-due
Ongoing 2007-005647-14 Gamma Delta T Cells and their role in the acute phase reaction to intravenous bisphosphonates not-yet-due
Ongoing 2007-006227-12 A randomised, placebo controlled study of nebulised magnesium in acute severe asthma in children not-yet-due
Ongoing, reported early 2007-007591-42 A Phase II single-arm trial to evaluate cisplatin and gemcitabine chemotherapy in combination with sunitinib for first-line treatment of patients with advancd transitional carcinoma of the urothelium. not-yet-due
Ongoing, reported early 2007-007615-82 A Phase I/II single-arm trial to evaluate the combination of cisplatin and gemcitabine with the mTOR inhibitor temsirolimus for treatment of advanced cancers, including first-line treatment of patient... not-yet-due
Not reported 2008-000475-25 Randomised, controlled, double-blind, parallel group clinical trial evaluating the efficacies and safety of methyl-aminolevulinate photodynamic therapy and intense pulsed light, administered as place... 2012-08-13 due-trials
Ongoing, reported early 2008-001394-15 A multi-centre randomised phase II study of induction chemotherapy followed by gemcitabine or capecitabine based chemoradiotherapy (CRT) for locally advanced non-metastatic pancreatic cancer not-yet-due
Ongoing, reported early 2009-010140-33 A randomised phase II Trial of carboplatin and gemcitabine +/- vandetanib in first line treatment Of advanced Urothelial cell Cancer in patients who are not suitable to receive cisplatin not-yet-due
Ongoing 2009-012151-23 A randomised phase II study of Irinotecan, 5-Fluorouracil and Folinic Acid (FOLFIRI) with or without the addition of an endothelin receptor antagonist in patients with metastatic colorectal cancer aft... not-yet-due
Not reported 2010-018837-23 A randomised Phase II study of carboplatin with or without the addition of the ETAR inhibitor ZD4054 as treatment for patients with metastatic breast cancer. 2011-08-09 due-trials
Ongoing 2010-021444-18 TO ESTABLISH THE FEASIBILITY OF COMBINING EITHER THE TYROSINE KINASE INHIBITOR AC220 OR THE CXCR4 INHIBITOR PLERIXAFOR OR THE HSP90 INHIBITOR, GANETESPIB, WITH CHEMOTHERAPY IN OLDER PATIENTS WITH ACUT... not-yet-due
Reported results 2010-023083-40 A Phase II study of neoadjuvant chemotherapy given before SCPRT as treatment for patients with MRI-staged operable rectal cancer at high risk of metastatic relapse 2015-04-14 due-trials
Ongoing, reported early 2010-023476-23 Seal or Varnish? A Randomised Trial To Determine The Relative Cost And Effectiveness Of Pit And Fissure Sealants And Fluoride Varnish In Preventing Dental Decay not-yet-due
Not reported 2010-024380-41 A pilot study to assess the effect of regulatory T-cell depletion on 5T4-containing MVA(TroVax®)vaccination in patients with inoperable metastatic colorectal cancer 2016-06-23 due-trials
Ongoing 2011-000749-19 Bloodwise and NCRI Working Group Pick a Winner Programme (LI-1) Trial not-yet-due
No trial status on register 2011-003591-37 Children with Eczema Antibiotic Management Study (CREAM) bad-data
Ongoing 2011-004854-25 TRON: A randomised, double blind, placebo-controlled study of RAD001 (Everolimus) in the treatment of neurocognitive problems in tuberous sclerosis. not-yet-due
Ongoing 2012-004117-14 A feasibility study to inform the design of a randomised controlled trial to identify the most clinically and cost effective length of Anticoagulation with Low molecular weight heparin In the treatmen... not-yet-due
Ongoing, reported early 2012-005123-32 Oral steroids for the resolution of otitis media with effusion in children study (OSTRICH) not-yet-due
Reported results 2012-005511-11 Fibrinogen concentrate versus placebo for treatment of postpartum haemorrhage: a prospective double blind randomised control trial 2015-11-26 due-trials
Reported results 2013-000389-12 ANti-psychotic Drug REduction in primary care for Adults with Learning Disabilities (ANDREA-LD): A Randomised Double-blind Placebo Controlled Trial 2016-06-30 due-trials
Not reported 2013-000501-22 A national cancer research institute acute myeloid leukaemia working group pilot trial under the auspices of the cardiff experimental cancer medicine centre to establish the feasibility of combining t... 2015-06-03 due-trials
Other 2013-002730-21 A Trial for Older Patients with Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome not-yet-due
Not reported 2014-000540-15 Prostaglandin F2-alpha eye drops (Bimatoprost) in thyroid eye disease: a randomised controlled double blind crossover trial 2016-04-15 due-trials
Ongoing 2014-002195-90 Adults with acute myeloid leukaemia or high-risk myelodysplastic syndrome (AML19) not-yet-due
Ongoing 2014-005088-34 A randomised controlled, double blind trial investigating the efficacy of fluoxetine treatment in improving memory and learning impairments in patients with mesial temporal lobe epilepsy: Fluoxetine, ... not-yet-due
Ongoing 2015-002281-23 A phase 2 study of the monocyte-targeted histone deacetylase inhibitor tefinostat (CHR-2845) in chronic myelomonocytic leukaemia (CMML) not-yet-due
Ongoing 2015-003934-28 Enhanced Epidermal Antigen Specific Immunotherapy trial -1 (EE-ASI-1): A Phase 1a study of gold nanoparticles administered intradermally by microneedles to deliver immunotherapy with a proinsulin deri... not-yet-due